| 000 | 01895 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516071039.0 | ||
| 264 | 0 | _c20120308 | |
| 008 | 201203s 0 0 eng d | ||
| 022 | _a1096-0007 | ||
| 024 | 7 |
_a10.1016/j.exer.2011.11.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuriyan, A E | |
| 245 | 0 | 0 |
_aElectrophilic PPARĪ³ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring. _h[electronic resource] |
| 260 |
_bExperimental eye research _cJan 2012 |
||
| 300 |
_a136-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aActins _xgenetics |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCell Transdifferentiation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCollagen Type I _xgenetics |
| 650 | 0 | 4 |
_aCornea _xcytology |
| 650 | 0 | 4 |
_aFibroblasts _xcytology |
| 650 | 0 | 4 |
_aFibronectins _xgenetics |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aFluorescent Antibody Technique, Indirect |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aMyofibroblasts _xcytology |
| 650 | 0 | 4 |
_aOleanolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPPAR gamma _xmetabolism |
| 650 | 0 | 4 |
_aProstaglandin D2 _xanalogs & derivatives |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xpharmacology |
| 700 | 1 | _aLehmann, G M | |
| 700 | 1 | _aKulkarni, A A | |
| 700 | 1 | _aWoeller, C F | |
| 700 | 1 | _aFeldon, S E | |
| 700 | 1 | _aHindman, H B | |
| 700 | 1 | _aSime, P J | |
| 700 | 1 | _aHuxlin, K R | |
| 700 | 1 | _aPhipps, R P | |
| 773 | 0 |
_tExperimental eye research _gvol. 94 _gno. 1 _gp. 136-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.exer.2011.11.018 _zAvailable from publisher's website |
| 999 |
_c21399888 _d21399888 |
||